Article Figures & Data
Tables
Characteristic Number Percent Age, years 16–21 39 17 22–29 102 45 30–39 77 34 40+ 9 4 Total 227 100 Types of insurance Medicaid 53 24 Private Insurance 89 39 Uninsured/Self Pay 80 35 Unknown 5 2 Total 227 100 Gestational age <6 wk 66 29 6 wk–6 wk 6 d 67 30 7 wk–7 wk 6 d 63 28 8–9 wk 31 13 Total 227 100 ARM Protocol FDA Product Labeling Gestational age limit 63 days 49 days Mifepristone dose 200 mg orally 600 mg orally Misoprostol dosing 800 μg vaginally 400 μg orally Home self-administration Office administration 24–72 h later (day 1–3) 48 h later (day 2) Office follow-up visit day 4–8 day 10–15 Minimum office visits 2 3 Cost $90 for mifepristone $270 for mifepristone 2 office visits 3 office visits $4 for misoprostol $2 for misoprostol ARM — Abortion Rights Mobilization trials, FDA — Food and Drug Administration.
Criteria Number Comments Total number of medical abortions 236 3 women had a second medical abortion during this period Excluded because they did not return and were unable to be contacted for follow-up examination 8 These patients might return, as several patients did months later Excluded for failure to adhere to protocol 1 This patient underwent a suction procedure for unknown indications Patients who adhered to the protocol and had complete follow-up care 227 226 had a successful medical abortion using mifepristone and misoprostol according to study protocol Genuine method failures 1 This patient had a continuing pregnancy and required a suction procedure to complete her abortion Patients who underwent dilatation and curettage elsewhere 1 This patient provided by telephone follow-up information about her emergency department visit
